Health
Clinical trials of new treatments for COVID-19 often do not include vulnerable populations – News-Medical.Net
Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by…
Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.
The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine.
This study highlights the blind spot in how clinical trials are done in the United States. Researchers, hospitals and pharmaceutical…
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business20 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business19 hours agoHere’s what analysts expect for the BHP share price in the coming year